Prediabetes

The Natural History of Type 2 Diabetes Varies Between Clinical Subphenotypes of At-Risk Individuals

by Prateek Chopra | June 25, 2026 | Diabetes Conferences | ADA 2026 Research Objective Methods High-Risk Metabolic Clusters Study Population Changes in Insulin Sensitivity Changes in Beta-Cell Function Adiposity Trajectories Clinical Implications High-risk metabolic subphenotypes follow different pathways toward the development of T2D. While progressive insulin resistance predominates in some individuals, accelerated beta-cell deterioration drives diabetes onset in others, […]

The Natural History of Type 2 Diabetes Varies Between Clinical Subphenotypes of At-Risk Individuals Read Post »

Leave a Comment / Diabetes Conferences / bluetree.healthcare@gmail.com / July 29, 2026 / ADA 2026, Beta-Cell Function, Insulin Resistance, Personalized Diabetes Prevention, Prediabetes, Type 2 Diabetes (T2DM)

Prescribing Trends and Comparative Risk of Type 2 Diabetes Progression in Prediabetes by Antihyperglycemic Drug Class

by Prateek Chopra | June 24, 2026 | Diabetes Conferences | ADA 2026 Need for Diabetes Prevention Methods Primary Outcome Risk of Progression to Type 2 Diabetes Clinical Implications In this large real-world analysis, GLP-1RAs, GIP/GLP-1RAs, and SGLT2 inhibitors were associated with significantly lower rates of incident T2D compared with metformin. Among these therapies, GIP/GLP-1RAs provided the greatest protection against